Kenneth R. Shroyer, MD, PhD
SUNY Distinguished Professor
The Marvin Kuschner Professor and Chair
Department of Pathology
President, Stony Brook Pathologists, UFPC
Basic Sciences Tower, Level 9 Rm 140
Stony Brook Medicine
Stony Brook, NY 11794-8691
Tel: (631) 444-3000
Fax: (631) 444-3424
Email: Kenneth.Shroyer@stonybrookmedicine.edu
Personal statement: Dr. Shroyer is Board Certified in Anatomic and Clinical Pathology (1991), with subspecialty certification in Cytopathology (1995). He is a general surgical pathologist with a subspecialty expertise in gynecologic oncology. He also has extensive experience in gynecologic and non-gynecologic cytopathology, including fine needle aspiration cytopathology. Dr. Shroyer pioneered novel methods to improve the accuracy of the cytologic and histologic classification of tumors. He completed his graduate training in Experimental Pathology under the supervision of Dr. Paul K. Nakane, the inventor of the immunoperoxidase method, invented the method of DNP labeling of nucleic acid probes, and was a pioneer in the development of methods for in situ hybridization of mRNAS in the early 1980s. He subsequently authored the first report on the analysis of x-chromosome inactivation in archival tissues as a marker of clonality. Dr. Shroyer contributed to the early validation of tyramide-based signal amplification technology for in situ hybridization and high sensitivity immunohistochemistry and he has been engaged in the development of novel approaches for antibody labeling using nanoparticles for both in vivo imaging and for immunohistochemical applications in collaboration with scientists in biomedical engineering for over ten years. Ongoing areas of investigation in Dr. Shroyer’s laboratory are focusing on the discovery of the mechanistic basis of nuclear keratin 17 as a prognostic biomarker in carcinomas of the female genital tract, pancreas, and other anatomic sites.
MedicalResearch.com Keratin 17 Promotes Cancer Growth and Chemotherapy Resistance
Interview with Kenneth R. Shroyer, September 3, 2015
Education: |
|||
Institution and Location |
Degree | Year | Field of Study |
Colorado College, Colorado Springs, CO | B.A. | 1978 | Biology |
Univ. of CO Graduate School, Denver, CO | Ph.D. | 1983 | Experimental Pathology |
Univ. of CO School of Medicine, Denver, CO | M.D. | 1987 | Medicine |
Positions and Employment: |
|
1987-1988 | Intern, Anatomic and Clinical Pathology, UCHSC |
1988-1991 | Resident, Anatomic and Clinical Pathology, UCHSC |
1991 | Chief Resident in Pathology, UCHSC |
1991-1997 | Assistant Professor of Pathology, UCHSC |
1997-2001 | Associate Professor with tenure, UCHSC |
2002-2007 | Professor with tenure, UCHSC |
1991-2007 | Graduate Faculty, UCHSC, Graduate School |
1993-2007 | Director of Cytopathology, UCHSC |
2000-2007 | Director of Surgical Pathology, UCHSC |
2007-present | Marvin Kuschner Professor and Chair, Department of Pathology, Stony Brook Medicine |
2007-present | Graduate Faculty, Molecular and Cellular Biology Program, Stony Brook University |
2011-present | Graduate Faculty, Molecular and Cellular Pharmacology Program, Stony Brook University |
2011-present | Graduate Faculty, Molecular Genetics and Microbiology Program, Stony Brook University |
Other Experience and Professional Memberships (selected): |
|
2006-present | Associate Editor, Journal of Clinical Virology |
2004-present | Editorial Board, Human Pathology |
2002-present | American Society for Investigative Pathology |
2001-present | National Cancer Institute Study Section member* |
1993-present | American Society of Cytopathology |
1991-present | American Association for Cancer Research |
1991-present | U.S. and Canadian Academy of Pathology (Member of Scientific Advisory Board) |
Honors (selected): |
|
2025 | State University of New York Distinguished Professor |
2025, 2024 | Castle Connolly Top Doctors Awards |
2023 | Inducted as a Member of the National Academy of Inventors (NAI) |
2020, 2019 | Top Doctors Award |
2017, 2009-14 | Best Doctors in America Award |
2018 | Pancreatic Cancer Action Network Translational Research Award |
2017 | Cited by Medscape for senior authorship of the most widely read primary research paper in the field of Pathology, December 2017 |
2009 | Recognition for senior authorship of one of Human Pathology's top 10 cited articles |
1999 | Max Kade Austrian Scholarship Award, accorded to R. Lehner, based on our work on Analysis of Survivin Telomerase Expression in Placental Development and Endometrial Neoplasia |
1998 | Lucien J. Rubinstein Award for Best Paper on Neuro-oncology. Shared with B.K. |
1992 | Shannon Award, NIH |
1991 | Robert H. Fennell, Jr., M.D. Award, Department of Pathology, University of Colorado, HSC |
1987 | Joseph and Regina Glaser Student Research Award, UCHSC |
1985-1987 | Edgar and Marion Adler Scholar Award (only medical student to receive this award in two consecutive years), UCHSC |
Peer Reviewed Publications:
H-index: 71; 14,621 citations (as of 7/22/25)
*including IMAT, Applied Emerging Technologies for Cancer Res., Alliance of Glycobiologists for Detection of Cancer and Cancer Risk, SPOREs in Breast, Cervical, Endometrial, Ovarian, Skin Cancers, Lymphoma, Genitourinary, and Gastrointestinal Cancers and In Vivo Cellular and Molecular Imaging Centers (ICMICs), Cancer Target Discovery and Develop. (CTDD) Network<